Online training for care teams & individuals

Explore Learn to Care

Find your next step in care.

Your cart

Review your selected training

Ketamine and Esketamine: Schedule 8 Medicine Safety and Monitoring

Ketamine and Esketamine Training | Schedule 8 Safety Course

  • Code: KES809
Ketamine and esketamine training for care and nursing staff covering supervision, monitoring and escalation. Practical Schedule 8 safety course

Original price was: $199.Current price is: $99.

Share course:

Facebook
Email
WhatsApp
X
LinkedIn
Reddit
  • Duration Approx. 90 Minutes
  • Languages: English
  • Delivery: 100% online (mobile + desktop)
  • Certificate: Instant digital certificate on completion
  • Email us at: info@learntocare.com.au
  • Course renewal:
    6 months
  • Course Fees: $AUD $199 Original price was: $199.$99Current price is: $99.
Watch the course preview

Ketamine and Esketamine: Schedule 8 Medicine Safety and Monitoring

Ketamine and esketamine training for care and nursing staff

This ketamine and esketamine training gives care workers, nurses and provider teams practical guidance for supporting people receiving these Schedule 8 medicines. It covers ketamine and esketamine, different treatment contexts, routes of administration, professional scope, post-treatment monitoring and emergency escalation. Ketamine may be encountered in anaesthetic and pain-related contexts, while esketamine nasal spray may be used in specialist treatment for treatment-resistant depression. Both ketamine and esketamine are listed as Schedule 8 medicines in current Australian medicine information. This Schedule 8 safety course focuses on a critical boundary: having a medication plan does not automatically mean a worker is authorised to administer a particular medicine or formulation. Workers learn what to observe, what to document, when to escalate and how to support safe handover and continuity after treatment.

3. Why take this course?

Why ketamine and esketamine medication training matters

  • Recognise deterioration earlier by identifying sedation, dizziness, dissociation, altered perception, reduced responsiveness and respiratory concerns.
  • Understand professional boundaries so workers do not assume that a medication plan alone authorises ketamine or esketamine administration.
  • Support safer post-treatment care by understanding observation, falls risk, transport, handover and restrictions communicated by the treating service.
  • Identify interaction risks involving alcohol, opioids, benzodiazepines and other central nervous system depressants. Spravato medicine information specifically identifies CNS depressants as medicines or substances that may interact with treatment.
  • Build nursing and worker confidence when a person returns from specialist treatment or develops concerning symptoms.
  • Strengthen provider systems around Schedule 8 medication safety, incidents, documentation, worker scope and escalation.
Current Australian information for Spravato requires use in a clinic, hospital or doctor’s office under direct healthcare-professional supervision. Monitoring includes blood pressure, sedation and dissociation, with the person remaining under observation until clinically stable.

4. What you’ll gain

Practical Schedule 8 medicine safety and monitoring skills

By completing this ketamine medication safety course, you will be better able to:
  • Identify ketamine and esketamine as Schedule 8 medicines and recognise that their treatment settings and administration requirements can differ.
  • Distinguish between injectable ketamine and supervised intranasal esketamine treatment.
  • Check the person’s treatment instructions, worker role and authorised scope before providing medication-related support.
  • Recognise sedation, dizziness, dissociation, altered perception, nausea and increased falls risk.
  • Identify concerning reduced responsiveness, breathing problems or other unexpected deterioration requiring urgent escalation.
  • Recognise that esketamine can temporarily increase blood pressure and requires clinical monitoring around treatment.
  • Follow restrictions and discharge instructions communicated by the treating service, including transport and activity requirements.
  • Complete clearer handovers after treatment so the next worker understands observations, restrictions and escalation instructions.
  • Document incidents and changes accurately and communicate concerns to the appropriate clinician, supervisor or emergency service.
  • Avoid making independent decisions about additional doses, altered treatment or administration outside the person’s authorised clinical plan.
Spravato can cause sedation, dizziness, dissociation and respiratory depression, and its Australian medicine information requires monitoring until the treating healthcare professional considers the person clinically stable.

5. Who’s it for?

Schedule 8 training for workers, nurses and provider teams

This ketamine and esketamine training is designed for individuals and organisations that may support people before, during or after ketamine or esketamine treatment.
  • Registered and enrolled nurses
  • NDIS and disability support workers
  • Aged care and community care workers
  • Mental health support workers
  • Allied health professionals
  • Supported accommodation and SIL teams
  • Team leaders and service managers
  • Workers supporting transport or post-treatment handover
  • Provider managers responsible for medication safety, clinical risk and workforce training
It suits both individual professional development and structured provider-team training. The level of medication involvement must always remain within the worker’s role, qualifications and applicable clinical and legal requirements.

6. What’s included?

Online ketamine and esketamine Schedule 8 safety course

  • Short, practical online video lessons
  • Four modules covering ketamine, esketamine, professional scope, monitoring and escalation
  • Scenario-based training involving post-treatment sedation, deterioration, transport, interacting sedatives and handover
  • Practical examples covering supervised esketamine treatment and injectable ketamine contexts
  • Knowledge checks and online quizzes
  • Downloadable resources for workplace reference
  • Certificate of Completion – Ketamine and Esketamine: Schedule 8 Medicine Safety and Monitoring
  • Learner progress and completion records through the Learn to Care online dashboard
  • Team reporting for eligible organisation accounts
  • Public online certificate verification

7. Which Practice Standards does this course align to?

This course supports relevant medication safety, worker competence, risk, incident management and communication requirements. Completion alone does not authorise a worker to administer ketamine or esketamine, replace professional scope requirements or demonstrate full regulatory compliance. State and territory laws, professional standards, medication policies, clinical instructions, delegation requirements and the specific treatment setting must also be followed.

NDIS Practice Standards

  • Management of Medication – Provision of Supports Environment: Supports workers to follow current medication information, monitor effects, recognise adverse responses and understand safe medication-related responsibilities. The NDIS Practice Standards expect medication to be administered, stored and monitored safely and medication incidents to be prevented or appropriately managed.
  • Safe Environment – Provision of Supports Environment: Supports workers to identify risks following treatment, including falls, deterioration and changes requiring involvement from healthcare or allied health providers.
  • Risk Management – Provider Governance and Operational Management: Supports identification and management of medication, sedation, falls, transport, interaction and clinical deterioration risks.
  • Incident Management – Provider Governance and Operational Management: Reinforces recognition, documentation, reporting and review of medication-related incidents and unexpected deterioration.
  • Human Resource Management – Provider Governance and Operational Management: Supports provider systems that identify worker responsibilities, scope and limitations and provide relevant training and supervision.

Strengthened Aged Care Quality Standards

  • Standard 5 – Clinical Care, Outcome 5.3: Safe and quality use of medicines: Directly supports safe medication systems, defined worker roles, monitoring, documentation, adverse-event escalation and high-risk medicine management.
  • Standard 2 – The Organisation, Outcome 2.4: Risk management: Supports identification and management of risks associated with sedation, falls, treatment transitions and clinical deterioration.
  • Standard 2 – The Organisation, Outcome 2.5: Incident management: Supports appropriate response, documentation and escalation when medication-related incidents or adverse events occur.
  • Standard 2 – The Organisation, Outcome 2.9: Human resource management: Supports workforce training, supervision and clear responsibilities for workers involved in medication-related care.
  • Standard 3 – The Care and Services, Outcome 3.3: Communicating for safety and quality: Supports accurate handover of clinical information, risks, deterioration and treatment instructions between workers, health professionals and other people involved in care.
  • Standard 5 – Clinical Care, Outcome 5.4: Comprehensive care: Supports recognition and communication of deterioration and coordinated responses to changing clinical needs.
The strengthened Aged Care Quality Standards have applied since 1 November 2025.

8. FAQ

Is the ketamine and esketamine training online and self-paced?

Yes. The ketamine and esketamine training is completed online, allowing workers and nurses to progress through the video lessons, scenarios and quizzes at their own pace.

Do I receive a certificate after completing the Schedule 8 safety course?

Yes. Successful completion provides a Certificate of Completion – Ketamine and Esketamine: Schedule 8 Medicine Safety and Monitoring. Learn to Care certificates can also be checked through the public certificate verification system.

Are ketamine and esketamine both Schedule 8 medicines?

Yes. Current Australian medicine information lists both ketamine and esketamine as Schedule 8 controlled medicines. Their formulations, indications and administration settings can differ significantly, so workers must follow the instructions applying to the specific treatment.

Can a support worker administer ketamine or esketamine if there is a medication plan?

A medication plan alone should not be treated as automatic authorisation to administer every medicine or formulation. Worker scope, qualifications, state or territory requirements, provider procedures and specific clinical instructions all matter. For example, Australian information for injectable ketamine describes administration by a doctor or nurse, while Spravato is self-administered by the patient under direct supervision of a healthcare professional in a clinic, hospital or doctor’s office.

What happens during supervised esketamine treatment?

Spravato nasal spray is used by the patient under direct healthcare-professional supervision. The healthcare professional monitors the person before and after treatment, including blood pressure, sedation and dissociation, and determines when they are clinically stable enough to leave.

Can someone drive after Spravato treatment?

Australian medicine information states that people receiving Spravato should not drive or operate machinery until the next day after a restful night’s sleep. Workers should also follow any additional restrictions or discharge instructions provided by the treating service.

Does this course count as professional development or CPD?

The course can support professional development and may be recorded as CPD where it meets the requirements of your employer, registration body or professional association. Nurses and allied health professionals should check the requirements that apply to their registration and individual learning plan.

How does this Schedule 8 safety course help providers with audits and compliance?

It provides structured evidence that workers have completed training covering Schedule 8 medicine safety, professional scope, monitoring, deterioration, incidents, documentation and handover. It supports relevant NDIS Practice Standards and strengthened Aged Care Quality Standards but should sit alongside competency assessment, workplace policies, supervision and clinical governance systems.  

Are you an NDIS or aged care provider?

Stop paying the seat tax!

Train your whole team with just one membership. Unlimited seats. No Cap! Audit-ready, Instant certificates and 1,200 (video) learning modules. 100% Online.

Buy Singular course:

Original price was: $199.Current price is: $99.

Resources

Related Resources